News
The challenges and opportunities of clinical trials in developing countries
Conducting more clinical trials in developing countries is of benefit because these populations are underrepresented in research, but doing trials in resource poor settings...
News
Novartis drug Gilenya® shows long-term efficacy and safety
New long-term data for Gilenya® (fingolimod), the only oral therapy approved to treat people with relapsing forms of multiple sclerosis (MS), show a sustained...
News
Bristol-Myers Squibb Foundation announces $6 million in grants
The Bristol-Myers Squibb Foundation has announced $6 million in additional grants through its Together on Diabetes™ initiative that will help more adults living with...
News
Alzheimer’s vaccine trial a success
A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer's disease. ...
News
Abbott presents phase 3 study results for investigational use of HUMIRA
Abbott announced results from the Phase 3 ABILITY-2 investigational study of HUMIRA in patients with active peripheral spondyloarthritis (PSpA) who have not been diagnosed with...
News
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according...
News
Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma
Results from a study published online in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.